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Abstract
Preterm birth is a leading cause of morbidity and mortality in infants. Genetic and environ-
mental factors play a role in the susceptibility to preterm birth, but despite many investiga-
tions, the genetic basis for preterm birth remain largely unknown. Our objective was to
identify rare, possibly damaging, nucleotide variants in mothers from families with recurrent
spontaneous preterm births (SPTB). DNA samples from 17 Finnish mothers who delivered
at least one infant preterm were subjected to whole exome sequencing. All mothers were of
northern Finnish origin and were from seven multiplex families. Additional replication sam-
ples of European origin consisted of 93 Danish sister pairs (and two sister triads), all with a
history of a preterm delivery. Rare exonic variants (frequency <1%) were analyzed to iden-
tify genes and pathways likely to affect SPTB susceptibility. We identified rare, possibly
damaging, variants in genes that were common to multiple affected individuals. The gluco-
corticoid receptor signaling pathway was the most significant (p<1.7e-8) with genes
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containing these variants in a subgroup of ten Finnish mothers, each having had 2–4
SPTBs. This pathway was replicated among the Danish sister pairs. A gene in this pathway,
heat shock protein family A (Hsp70) member 1 like (HSPA1L), contains two likely damaging
missense alleles that were found in four different Finnish families. One of the variants
(rs34620296) had a higher frequency in cases compared to controls (0.0025 vs. 0.0010, p =
0.002) in a large preterm birth genome-wide association study (GWAS) consisting of moth-
ers of general European ancestry. Sister pairs in replication samples also shared rare, likely
damaging HSPA1L variants. Furthermore, in silico analysis predicted an additional phos-
phorylation site generated by rs34620296 that could potentially affect chaperone activity or
HSPA1L protein stability. Finally, in vitro functional experiment showed a link between
HSPA1L activity and decidualization. In conclusion, rare, likely damaging, variants in
HSPA1L were observed in multiple families with recurrent SPTB.
Author summary
Preterm birth is the leading cause of infant mortality, and prematurity is further associated
with serious morbidities in later life. Genetic and environmental risk factors play a role in
the susceptibility to preterm birth. Despite numerous studies, the genetic basis for preterm
birth remains poorly defined. We investigated the presence of rare, possibly risk associ-
ated nucleotide variants in mothers with spontaneous preterm births (SPTB). The first set
of mothers with family history of recurrent preterm births was of northern Finnish origin.
An additional set of mothers (sister pairs, both giving birth preterm) of European origin
was also studied. Whole exome sequencing identified multiple rare, likely damaging
HSPA1L variants in several families affected by SPTB, and this gene was associated with
the glucocorticoid receptor signaling pathway. Potential involvement of one of the
HSPA1L variants in SPTB was further supported by large GWAS dataset. In addition, this
variant alters protein post-translational modification potential, and thus may affect pro-
tein stability and its function as a chaperone.
Introduction
Preterm birth (PTB), defined as birth before 37 completed weeks of gestation, is a major global
public health concern. Worldwide, over 15 million infants (more than one in ten babies) are
born preterm and of those, more than one million die from complications related to preterm
birth each year [1]. Preterm birth and its complications are the leading cause of neonatal
deaths and have become the major cause of death among children under five years old [2].
Moreover, preterm infants are at increased risk, not only of short-term complications but also
of life-long disabilities, such as respiratory and cognitive disorders [1]. Preterm birth also
increases the risk of adult-onset disorders, such as obesity, diabetes and cardiovascular diseases
[3, 4]. Currently, there is no generally effective method for prevention of preterm delivery.
The majority (~70%) of preterm births occur after spontaneous onset of labor, with or with-
out preterm prelabor rupture of the membranes (PPROM) [5]. Most spontaneous preterm
births (SPTBs) are idiopathic [1, 5]; however, recurrence of preterm birth among mothers and
within families indicates that genetic factors may be important. Genetic factors are estimated
to account for 25–40% of the variation in birth timing [6], with the maternal genome playing
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the major, but not only, role in predisposition to preterm birth [7–11]. Despite many studies
of the genetics of SPTB [6, 12, 13], only a few variants have been robustly associated with this
outcome [14], and their functional implications are unclear.
Previous genome-wide association studies (GWAS) of SPTB have involved common vari-
ants, but they explain only a small portion of the genetic risk. The role of rare variants in SPTB
has been essentially unexplored. Whole exome sequencing (WES) in families offers a compre-
hensive method to identify rare variant associations with disease, including almost complete
coverage of the protein coding regions of the genome. Even though studies of rare variants
underlying Mendelian disorders have revealed novel genes [15, 16], using WES to study com-
plex multifactorial syndromes remains a challenge [17]. Previous sequencing studies of PTB
[18] or PPROM [19, 20] have focused only on a set of candidate gene regions and, conse-
quently, have missed the majority of the coding regions of the genome. In contrast to whole
genome sequencing, WES is more cost effective and has the advantage of providing more eas-
ily interpreted results.
We performed a WES study using families under the hypothesis that familial recurrence
is influenced by rare variants with large individual effects on SPTB susceptibility. Such an
approach has the potential of identifying genes containing rare variants shared in these multi-
plex families, as well as genes in pathways common across families. This method applies a
hypothesis-free testing approach to identify potentially novel candidate genes for SPTB.
Results
Ingenuity variant analysis and pathway analysis
Seventeen mothers from seven northern Finnish multiplex families (Discovery cohort) and an
additional 192 mothers from 95 Danish families (Replication cohort) were sequenced using
WES. The pedigrees of the multiplex Finnish families are shown in S1 Fig. For the Discovery
cohort, all samples (except one that was excluded from subsequent analyses) passed the quality
control parameters used for the clinical exome sequencing at the CMH; quality control cutoffs
were 85% reads aligned, 80% aligned with alignment quality of 20 or greater. For these sam-
ples, the mean and median heterozygous/homozygous variant ratios were 0.765 and 0.748,
respectively. Prior to variant filtering in Ingenuity, the mean/median numbers of nucleotide
variant calls per individual were 318,767/326,474 (Discovery cohort) and 221,682/184,381
(Replication cohort). This difference in variant calls between the Discovery and Replication
populations is likely due the fact that populations were sequenced using different Next Genera-
tion Sequencing platforms, Illumina for Discovery cohort and Complete Genomics for Repli-
cation cohort, and their respective primary quality control measures and variant calling
methods were thus different. Mean transition/transversion (Ti/Tv) ratios were 2.2 and 2.0 for
Discovery and Replication exomes, respectively. An overview of the WES workflow is pre-
sented in Fig 1.
Discovery population. An initial nucleotide variant analysis (Ingenuity) was performed
in ten mothers (out of 17) with at least two recurrent spontaneous preterm deliveries. These
mothers were selected for the first analysis because they represent the most severe cases, i.e.,
multiple preterm deliveries. We further required that at least three of the cases (30%) had a
rare variant, that passed the quality control and prioritizing filters (e.g. likely damaging hetero-
zygous variants), in the same gene. For our purposes, rare variants are defined as minor allele
frequency (MAF) <1% in 1000 Genomes, ExAC or in NHLBI ESP. Requiring that at least 30%
of the cases had a variant in the same gene, ensured that identified genes are present in cases
from at least two different families. This analysis yielded 1,510 different variants in 406 genes.
Pathway analysis of these variants in the Ingenuity Variant Analysis identified 64 pathways
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with p<0.01 under a maternal dominant genetic model (S1 Table). The three most significant
pathways (p9.80e−7), observed in all ten mothers, were the glucocorticoid receptor signaling,
Fig 1. Overview of the whole exome sequencing study workflow. Abbreviations used QC; quality control, MAF; minor allele
frequency, RD; read depth, GQ; genotype quality.
https://doi.org/10.1371/journal.pgen.1007394.g001
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the estrogen receptor signaling and the AMPK signaling pathways. The genes mapping to
these pathways are shown in Table 1; many of these genes were present in more than one path-
way. Furthermore, when we included the 13 mothers with spontaneous singleton preterm
deliveries, and raised the requirement for candidate genes (harboring rare variants) to be
shared by at least four mothers, thereby requiring representation in at least two different fami-
lies, the same three pathways remained within the top five most significant pathways (for glu-
cocorticoid receptor signaling, estrogen receptor signaling and AMPK signaling pathways, the
p-values were 3.51e−8, 2.75e−6 and 2.99e−8, respectively).
We used a family-based analysis with a dominant genetic model with at least two affected
individuals within a family (five families) for additional Ingenuity Variant Analysis. Within a
family, affected mothers shared on average 444 variants (range 278–691) in 243 genes (range
173–381). Individual pathway analysis of each family revealed the glucocorticoid receptor sig-
naling pathway as common to all families and the estrogen receptor signaling pathway in three
families with p<0.01 (S2 Table). Several genes in the glucocorticoid receptor signaling path-
ways (AR, HSPA1L, NCOA3 and NCOR2) and in the estrogen receptor signaling pathways
(NCOA3 and NCOR2) were common to more than one family. These genes all had rare vari-
ants likely to be disease causative [21], and were present at a relatively low frequency in the
CMH database that was used as internal control data. This analysis only identified two families
with p<0.01 for the AMPK signaling pathway, and none of the genes in this pathway were
common to more than one family or passed further requirements relative to the control
dataset.
Replication population. The Ingenuity Variant Analysis of the replication samples (93
sister pairs) had an average of 807 (range 504–1553) rare nucleotide variants in 593 genes
(range 357–1112) shared by the two sisters within each family and assumed to be dominantly
acting. The glucocorticoid receptor signaling and estrogen receptor signaling pathways were
observed in 75 and 79 families with combined median p = 0.0003 and p<0.0001, respectively
(S3 Table). Within these two pathways, the genes from the Discovery analyses (AR, HSPA1L,
NCOA3 and NCOR2) were found in between 3 and 12 families from the Replication dataset
(Table 2). In an additional two Danish families with affected sister triads, there were 39 com-
mon pathways to the two families; the estrogen receptor signaling pathway had the second
lowest average p-value (p = 0.0003) and the glucocorticoid receptor signaling pathway had the
fifth lowest average p-value (p = 0.0009).
Table 1. Most significant pathway results for Finnish mothers with recurrent SPTB (n = 10).






Genes within the pathway identified by WES
Glucocorticoid receptor
signaling
1.673E-8 13 36 AR, FOXO3, HSPA1L, KAT2B, MAP3K1, NCOA3, NCOR1, NCOR2, NR3C2, PIK3R1,
POLR2J2/POLR2J3, SMARCA2, TBP
Estrogen receptor signaling 5.067E-7 8 27 CTBP2, KAT2B, MED15, NCOA3, NCOR1, NCOR2, POLR2J2/POLR2J3, TBP
AMPK signaling 9.804E-7 10 28 AK2, CHRNA3, FOXO3, KAT2B, MLST8, PFKM, PIK3R1, PPP2R2B, SMARCA2, TSC2
1P-value is calculated using a Fisher’s Exact Test based on the distinct sets of genes at the currently-selected filter cascade step, and those that are known to be associated
with a given pathway. P-values <0.05 indicate that there are significantly more genes within the pathway than expected by chance.
https://doi.org/10.1371/journal.pgen.1007394.t001
Table 2. Pathway results for Danish sister pairs (n = 93); showing only genes related to the Discovery findings.
Rank Pathway name No. of Families Average p-value Median p-value Gene (no. of families)
7 Estrogen receptor signaling 79 0.00073 0.00004 NCOA3 (10), NCOR2 (12)
10 Glucocorticoid receptor signaling 75 0.00124 0.00034 AR (3), HSPA1L (5), NCOA3 (10), NCOR2 (11)
https://doi.org/10.1371/journal.pgen.1007394.t002
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Comparison of data obtained from different WES software tools and
comparison of rare variants shared within families in Discovery and
Replication populations
Three software programs (Ingenuity Variant Analysis, Varseq and the CMH Variant Ware-
house) were used to assess common shared (by affected mothers per family) rare variants.
Only those variants that passed the prioritizing steps with at least two of the annotating soft-
ware tools were considered valid and are described below (summarized in S4 Table). The bene-
fits of comparing data obtained from multiple software is that it minimized the possibility of
picking up falsely called variants that passed quality control filters only by one software. This
approach resulted in a total of 844 variants in the Discovery population. For the Replication
population, we combined and compared the shared rare variants passing the annotation and
prioritizing steps of Ingenuity Variant Analysis and Varseq; a total of 8431 variants passed the
filters of both software tools. The CMH Variant Warehouse was not available for the Replica-
tion set. For both populations, variants were categorized as loss of function, moderate, or
other, according to their predicted consequences, i.e. pathogenicity (S5 Table). We further
compared the list of variants resulting from the family-based analyses (as described above)
between the Discovery and Replication populations. Numbers of common genes and variants
for both populations are shown in S2 Fig. There were 72 rare variants that were found in both
populations in 72 genes (S6 Table).
HSPA1L variants associate with preterm birth in GWAS data of 40,000
mothers
Rare single nucleotide variants from HSPA1L [heat shock protein family A (Hsp70) member 1
like], identified by the Discovery Ingenuity pathway analysis, were further investigated using
imputed GWAS data that also included variants with MAF <1%. In the Discovery set, variants
in AR, NCOA3 and NCOR2 were either CAG repeat length polymorphisms, in-frame deletions
or insertions, respectively, and were, therefore, not investigated in the GWAS datasets. Three
independent GWAS datasets were used, one of general European ancestry containing more
than 40,000 mothers of live births (23andMe dataset) and two from Northern Europe contain-
ing 4,600 and 600 mothers (Nordic and northern Finnish datasets, respectively). In the large
23andMe preterm birth GWAS dataset, the minor allele of rs34620296 in HSPA1L, which is in
the glucocorticoid receptor signaling pathway, was found to be more common in cases than in
controls (case frequency 0.0025 vs. control frequency 0.0010, p = 0.002; Table 3). This associa-
tion was also significant for gestational age as a continuous trait (gestational age as weeks;
p = 0.0016, effect -0.8238, standard error 0.2608). The HSPA1L variants from the Discovery
Table 3. HSPA1L variants in the large GWAS data and their association to SPTB.
Rs# Chr Position1 Alleles Protein change MAF in EA2 GWAS3 case/control frequencies GWAS3 p-value
rs34620296 6 31778948 C/T Ala268Thr 0.0014 0.0025/0.0010 0.0022
rs150472288 6 31779089 C/T Val221Ile 0.0001 Not present -
rs482145 6 31778314 A/G Thr479Met 0.0000 0.0000/0.0002 NS
rs139193421 6 31779723 T/C Ile9Met 0.0002 Not present -
1position in GRCh37.p13.
2Frequency for European American (EA) population according to ESP6500: NHLBI GO Exome Sequencing Project (ESP), Exome Variant Server (http://evs.gs.
washington.edu/EVS/).
3GWAS set including over 40,000 mothers. Association to SPTB; mother investigated as affected i.e. giving birth preterm.
https://doi.org/10.1371/journal.pgen.1007394.t003
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(rs34620296 and rs150472288) and the Replication (rs482145, rs139193421) analyses are listed
in detail in Table 3. In the two smaller GWAS datasets, however, these four HSPA1L variants
were absent or not significant. Lack of significance may be due to smaller numbers of individu-
als, especially in cases.
Sanger sequencing to validate HSPA1L variants and to genotype additional
family members
Sanger sequencing confirmed the genotypes of the two rare HSPA1L missense variants
(rs34620296 and rs150472288) in the samples from the Discovery cohort. The rare HSPA1L
variants were observed in a total of six mothers from four unrelated families. Additional family
members with available DNA were sequenced for these variants. Interestingly, in two of the
families, female carriers of the maternally inherited rs34620296 minor T-allele were born pre-
term, whereas in the other two unrelated families the male carriers of maternally inherited
rs150472288 minor T-allele were born preterm. However, numbers of minor allele carriers are
too small for any definite gender related conclusions.
Assessing the potential functional impact of the rare HSPA1L variants
Pathogenicity predictions for rs34620296 and rs150472288 derived from the Discovery cohort
as well as for rs482145 and rs139193421 from the Replication cohort were assessed using in sil-
ico tools SIFT and PolyPhen-2, and all these variants were predicted as damaging and proba-
bly/possibly damaging, respectively (Table 4). In addition, MutationTaster and
MutationAssessor predicted all four variants as disease causing and predicted functional
(high), respectively. According to the Combined Annotation Dependent Depletion (CADD)
score (>20), all of these variants, except for rs139193421, are among the top 1% of deleterious
variants in human genome (Table 4).





In silico prediction of
functional effect2
RegulomeDB HaploReg v4.1
SIFT PolyPhen2 Chromatin State: (Example tissue/cell
line)
Tissue/cell line: (Active chromatin state3a,b or
Enriched promoter Histone marks3c,d,e,f)
DNAse
rs34620296 29.7 Damaging Probably
damaging
Active TSS5a (Hela-S3)4 Strong
transcription (e.g. T cell subtypes5, ovary,
fetal adrenal gland)
HeLa-S3 (a, d, e, f); Primary T cell subsets5 from
peripheral blood (c, d, e)
NA
rs150472288 26.4 Damaging Probably
Damaging
Strong transcription (e.g. T cell
subtypes5, ovary, fetal adrenal gland)
Primary T cell subsets5 from peripheral blood (c, d, e) Ovary
rs482145 28.1 Damaging Probably
damaging
Active TSS (Foreskin Fibroblast Primary
Cells) Strong transcription (e.g. T cell
subtypes5, ovary)
Foreskin Fibroblast Primary Cells (a, b, c, d, e);
Primary T cell subsets5 from peripheral blood (c, d, e)
NA
rs139193421 NA Damaging Possibly
damaging
NA Strong transcription enhancers, Genic enhancers,
Enhancers and histone marks (c, d, e) in Primary T cell
subsets5 from peripheral blood
Psoas
Muscle
1CADD Score >20 = variant is amongst top 1% of deleterious variants in human genome
2In silico functional effect predictions: SIFT and PolyPhen-2 annotated by Varseq
3a:Active TSS (TssA), active transcription start site, b:Poised Promoter (PromP), c:H3K4me1_Enhancer, d:H3K4me3_Promoter, e:H3K27ac_Enhancer, f:
H3K9ac_Promoter
4HeLa-S3 = HeLa-S3 Cervical Carcinoma Cell Line
5Primary T cell subsets included e.g. effector/memory, regulatory, helper (memory and naïve), CD8+ cells.
https://doi.org/10.1371/journal.pgen.1007394.t004
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To assess potential consequences of these variants on transcriptional activity, we evaluated
them for evidence of histone modification or DNase I hypersensitivity. In silico tools HaploReg
4.1 and/or RegulomeDB showed that all four variants were in regions that had histone marks,
as well as strong transcriptional regulatory signatures in various cells of the immune system,
especially in T lymphocytes from peripheral blood (Table 4). Evidence of an active transcrip-
tion start site was predicted in the HeLa-S3 Cervical Carcinoma Cell Line for rs34620296 and
in foreskin fibroblast primary cells for rs482145 (Table 4). Further evidence of active DNA
accessibility (DNAse) was found in ovarian tissue for rs150472288, and in psoas muscle tissue
for rs139193421 (Table 4). There was also evidence of a transcriptional effect of rs34620296
and rs150472288 (Discovery) in ovary and fetal adrenal gland. Together these results from
HaploReg 4.1 and RegulomeDB provide evidence for the potential involvement of HSPA1L
variants in the endocrine system, as well as in the adaptive immune cells. These variants could,
therefore, have a role in the etiology of SPTB.
We further investigated putative effects of HSPA1L rs34620296 on protein structure. This
variant was selected due to its association with SPTB in the large 23andMe GWAS dataset.
This variant causes an amino acid change from Alanine to Threonine at position 268
(Ala268Thr). According to the NetPhos 3.1 in silico prediction, Ala268Thr generates an addi-
tional phosphorylation site next to an existing phosphorylation site (T267-p) (S3 Fig). Further-
more, Ala268Thr is near an adenosine triphosphate (ATP) nucleotide-binding site located
downstream at position 270−277 (Fig 2A). Gain of phosphorylation may cause changes in
binding energy, modulate physio-chemical properties or stability kinetics and dynamics of the
protein functions such as strength of protein-protein interactions [22].
To investigate the possible effects of the missense variant on protein structure, the reference
HSPA1L protein structure and a structure including the Ala268Thr variant were compared
simultaneously using UCSF Chimera. There was not a visible change in the overlaid protein
structures (Fig 2B). Instead, there was a slight change in the chemical bond lengths (0.002Å)
of the adenosine diphosphate (ADP)-ligand binding amino acid side chains at positions
Glu270, Arg274 and Asp368, shown in the 3D model of the HSPA1L (Fig 2C). This may be
due to the change from a small size, and hydrophobic, (Ala) to medium size, and polar, (Thr)
residue. Such a change in the amino acid side chains could affect the binding efficiency of the
ADP molecule.
Tissue expression
To further explore possible underlying biological functionality, we investigated the tissue
expression established via HSPA1L, along with AR, NCOA3 and NCOR2, using HumanBase
(http://hb.flatironinstitute.org). HSPA1L was expressed in placental tissue with reasonable
confidence (0.65), and in ovarian (0.57) and fetal tissues (0.48) as well as in uterus (0.29). For
HSPA1L, AR, NCOA3 and NCOR2 together, the average expression confidence was high in pla-
centa (0.74), ovary (0.70), fetus (0.65), and moderate in uterus (0.29), indicating high confi-
dence for expression in female reproductive system overall (S4 Fig).
Functional consequences of the HSPA1L Ala268Thr variant
To determine whether the HSPA1L Ala268Thr (rs34620296) variant alters activity of the GR
signaling pathway, we analyzed the consequences of glucocorticoid exposure during deciduali-
zation. Human endometrial stromal fibroblasts were transfected with plasmids containing
either WT or Ala268Thr cDNA, or with empty vector serving as control. The cells were treated
with decidualization media for 72h in a presence of glucocorticoids (100nM dexamethasone)
as a surrogate of stress. Protein levels of HSPA1L and GR, as well as mRNA levels of Wnt
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Family Member 4 (WNT4) were measured. Cells transfected with the WT HSPA1L-pcDNA
3.1 trended to greater increases in cytosolic HSPA1L protein content than those transfected
with the Ala268Thr HSPA1L-pcDNA3.1 (mean ± SEM; 1.272 ± 0.142 vs. 0.893 ± 0.146,
respectively, p = 0.09) (Fig 3). Furthermore, the Western blot analysis showed that the
Fig 2. Effects of HSPA1L variants on protein sequence and structure. (A) HSPA1L is a 641-amino acid protein that consist of two major functional domains; an N-
terminal nucleotide-binding domain and a C-terminal substrate-binding domain, that are connected with interdomain linker. Locations of four HSPA1L variants from
whole exome sequencing (Discovery and Replication findings) are shown in the protein sequence. Purple diamonds represent ATP nucleotide-binding sites at positions
14−17, 204−206, 270−277 and 341−344. Green circles denote the additional phosphorylation site generated by Ala268Thr and the existing one T267-p. (B) In silico
comparison of higher order assembly of reference and modified (Ala268Thr) HSPA1L protein models containing an ADP molecule. Overlayed reference and Ala268Thr
molecules are presented as gold and light blue rounded ribbon structures, respectively. The interacting ADP molecule is shown as a stick model. (C) Closeup view of the
intermolecular contact interface of HSPA1L bound to the ADP molecule. Key interacting residues (amino acids) are shown and their corresponding side chains are
presented as stick molecules; nitrogen and oxygen atoms are indicated in blue and red, respectively. All interacting residues; THR16, TYR17, GLU270, LYS273,
ARG274, SER277 (not shown in figure) and ASP368, that bind to the ADP ligand showed small changes in the chemical bond lengths. Only changes of0.002Å are
shown in the figure (+/- lenght of Ala268Thr structure in relation to reference structure).
https://doi.org/10.1371/journal.pgen.1007394.g002
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relative cytosolic protein levels of GR differed significantly between the WT and Ala268Thr
groups with more GR present in the WT group than in the Ala268Thr group (mean ± SEM;
1.309 ± 0.099 vs. 0.993 ± 0.096, respectively, p = 0.04) (Fig 3; numerical data available in S7
Table).
Next, we determined the relative gene expression of WNT4 by qPCR. WNT4 is a critical
decidualization target found in the recent GWA study [14] associated with gestational length.
Increased expression of WNT4 was observed in the WT group, whereas, the Ala268Thr group
was less able to activate the WNT4-signaling pathway leading to a lower expression of WNT4
(p = 0.04).
Fig 3. HSPA1L and GR protein levels in decidualized human endometrial stromal fibroblasts. Cultured ESFs were transfected with WT or Ala268Thr
HSPA1L-pcDNA3.1 constructs or with empty pcDNA3.1 vector (control). Cells were treated with decidualization media supplemented with 100nM
dexamethasone (glucocorticoids) for 72h. Both cytosolic and nuclear protein were extracted, and HSPA1L and GR protein levels were measured by Western blot.
Band intensity of HSPA1L or GR was normalized to band intensity of the corresponding β-actin. Cytosolic (A) and nuclear (B) HSPA1L levels as well as cytosolic
(C) and nuclear (D) GR levels are shown for control (empty vector), WT and Ala268Thr sample groups. Each experiment was performed as triplicates in three
different passages (n = 9 each group, except n = 8 for nuclear control group) and bars represent mean + SEM. Significant p-value<0.05 is presented with an
asterisk. Cytosolic GR levels were significantly higher (p = 0.04) in the WT compared to the Ala268Thr group as well as in the WT compared to the control group
(p = 0.04).
https://doi.org/10.1371/journal.pgen.1007394.g003
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Discussion
To move beyond traditional case-control GWAS and family-based linkage studies, we per-
formed a case-only whole exome sequencing study designed to investigate the burden of rare
variants in families with recurrent SPTB. Whole exome sequencing enables the discovery of
rare, putatively functional variants associated with the etiology of complex disease on a gene-
by-gene or a pathway-by-pathway basis, and enrichment in multiplex families provides a
means to filter large-scale sequencing data.
Comparisons of mothers with recurrent preterm deliveries identified the glucocorticoid
receptor signaling pathway as a candidate for mediating the risk of SPTB. Specifically, within
this pathway, likely pathogenic missense variations in HSPA1L were found among four unre-
lated Finnish families (rs34620296 and rs150472288), and within Danish sister pairs (rs482145
and rs139193421). Notably, the rs34620296 minor allele variant was observed at a higher fre-
quency in cases than controls in a very large 23andMe GWAS set. These variants were also
identified via bioinformatics analyses as likely affecting either protein function or expression.
Further functional evidence linked HSPA1L activity and decidualization.
HSPA1L is a member of the Hsp70 superfamily and is near HSPA1A and HSPA1B within
the major histocompatibility complex class III region on chromosome 6. The HSPA1L protein
(also known as Hsp70-hom) is ~90% identical to HSPA1A and HSPA1B, also known as
Hsp70-1 and Hsp70-2, respectively [23, 24]. Heat shock proteins (HSPs) are highly conserved
cellular defense mechanisms for cell survival and are present in all cell types in all organisms.
Some HSPs are expressed constitutively, while others are stress-induced (e.g. heat, hypoxia,
oxidative stress, infection and inflammation) [25, 26]. Intracellular HSPs act as molecular
chaperones and, together with co-chaperones, stabilize existing proteins against aggregation,
mediate folding of newly translated proteins, and assist in protein translocation across intracel-
lular membranes [25, 27]. HSPs are categorized into families according to their approximate
molecular weight; of which Hsp70 (a group of proteins sized approximately 70 kDa) is the best
characterized. Potential involvement of stress-induced HSPA1A in adverse pregnancy out-
comes, including preeclampsia and PTB, has previously been suggested [28, 29]. Although,
studies of the role of HSPA1L and HSPA1L in pregnancy are lacking, there is some evidence of
involvement in adverse pregnancy outcomes such as preeclampsia [30].
The rare HSPA1L missense variants observed in our study, are in the nucleotide-binding
domain (NBD), except the rs482145, which is in the substrate-binding domain (SBD) (Fig 2).
ATP binds to the NBD, which is followed by the exchange from low-binding affinity ATP state
to high-binding affinity ADP state [29, 31, 32]. We showed that the non-synonymous variant
rs34620296 (Ala268Thr) generates an additional phosphorylation site near the nucleotide-
binding site. It showed a modest change in the binding efficiency at this site, which could affect
the interaction with ADP or HSPA1L stability itself, as suggested by our transfection studies.
In agreement with our findings, a previous study of Caucasian patients with inflammatory
bowel disease found that rare mutations in HSPA1L were significantly enriched in patients but
absent in healthy controls [33]. Interestingly, one of the associated rare variants was
Ala268Thr, and further in vitro biochemical assays of the recombinant HSPA1L showed
reduced chaperone activity with this variant [33]. There is also evidence that possibly connects
inflammatory bowel disease to adverse perinatal outcomes [34]. Additionally, a previous SPTB
study in African Americans found a common nonsynonymous HSPA1L variant, rs2075800, to
associate with SPTB [35]. Furthermore, a meta-analysis of previously PTB associated genes
linked HSPA1L and SPTB using Ingenuity Pathway Analysis [36].
Due to a very low incidence of the rare HSPA1L variants associating with SPTB in our
study, the anticipated attributable risk in the population level is probably small. However, the
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identification of the damaging alleles may facilitate the identification of causative pathways.
For instance, interaction between Hsp70 and Hsp90 chaperones as well as their co-chaperones
is essential in the maturation and inactivation of nuclear hormone receptors (e.g. glucocorti-
coid, androgen, estrogen and progesterone receptors) [37, 38]. In the absence of its ligand, glu-
cocorticoid receptor (GR) is bound to a complex constituting of Hsp40, Hsp70 and Hsp90
chaperones; this complex keeps the GR in a ligand-receptive conformation but remaining
transcriptionally inactive until ligand binding [38]. As shown previously [33], rare HSPA1L
variants can cause partial loss of HSPA1L chaperone activity, and therefore, altered function
or expression. Altered function of the chaperones can compromise the stability of the GR com-
plex, leading to an accumulation of partially unfolded proteins that are prone for aggregation
and degradation events [37].
Glucocorticoids, steroid hormones that mainly signal through the GR, have anti-inflamma-
tory and immunosuppressive actions. Glucocorticoid signaling communicates with estrogen
signaling pathways to tightly regulate the pro- and anti-inflammatory milieu in reproductive
tissues [39], and progesterone signaling, via nuclear GR, mediates anti-inflammatory and
immunosuppressive effects in genital tract during pregnancy [40, 41]. Sustaining a pregnancy
is a complex interplay and balance between the innate and adaptive immune cells in the repro-
ductive tissues and at the maternal-fetal interface. Imbalance between the inflammatory cells
can cause a breakdown of maternal-fetal tolerance leading to activation of labor (both term
and preterm). An untimely stimulus (e.g. stress, infection or inflammation) together with
impairments in the glucocorticoid receptor signaling pathway could impose an inadequate
response against inflammation or stress. This can elicit a shift from an anti-inflammatory to
pro-inflammatory microenvironment, causing a premature activation of labor initiating sig-
nals resulting in preterm birth [42, 43].
Possible limitations of our study are that the Discovery and Replication populations were
sequenced using different Next Generation Sequencing platforms, and primary quality control
measures and variant calling methods were thus different. In addition, Next Generation
Sequencing generates an enormous amount of data, which could lead to many sequencing arti-
facts that may be misidentified as variants. We attempted to minimize these artifacts by apply-
ing a variety of quality control filters and using a large internal control population to detect
potential sequencing or annotation errors. We also compared the results of variant annotation
and prioritizing filters from three different software tools to ensure reproducible results. Fur-
thermore, reported variants were confirmed by Sanger sequencing. Another possible limita-
tion was that our study did not include unrelated control samples. This limitation has been
partly overcome with the use of additional large GWAS datasets including control samples.
In conclusion, whole exome sequencing of families with recurrent occurrence of SPTB
enables identification of rare alleles influencing the predisposition to SPTB. Among the indi-
vidual genes, two minor alleles of HSPA1L had a strong association to SPTB in multiplex Finn-
ish families and the association of a specific minor allele was confirmed in a large GWAS set.
Furthermore, this variant was associated with altered modification and function of the protein.




Written informed consent was obtained from all individuals participating in this study, and
the study was approved by the Ethics committees of the participating centers: Oulu University
Hospital (78/2003, 73/2013), University of Southern Denmark (NVK#1302824), and
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University of Iowa (IRB#200608748). Individuals in the large European American GWAS
were research participants of 23andMe, Inc., a personal genetics company. All 23andMe par-
ticipants provided informed consent and participated in the research online, under a protocol
approved by the external AAHRPP-accredited IRB, Ethical & Independent Review Services
(E&I Review).
Study populations and inclusion criteria for SPTB cases
Discovery population: Northern Finnish multiplex families. A total of 17 mothers from
seven northern Finnish families were subjected to whole exome sequencing. This included 13
mothers with spontaneous preterm deliveries, of whom 10 had recurrent (2–4) spontaneous
preterm deliveries at less than 36 weeks of gestation. The remaining mothers were grandmoth-
ers (mothers of the affected index mothers) with pregnancy history including extremely pre-
term twin pregnancy or late preterm pregnancy. Pedigrees of the large families highlighting
the mothers selected for this study are presented in S1 Fig. The majority (five out of seven) of
these families have been included in our previous linkage studies [44, 45].
Unrelated families with history of recurrent preterm births were selected retrospectively
from the birth diaries of Oulu University Hospital from 1973–2003, and prospectively from
2003–2005. Descriptions of inclusion and exclusion criteria have previously been reported in
detail [44, 45]. A genealogical study was performed according to published criteria [46], and to
reveal close consanguinity or common residence, families were followed up to 17th century
using the provincial and national archives of Finland. All families were of the northern Finnish
origin. Furthermore, families with apparent maternal inheritance of SPTB were selected for
this study. Spontaneous preterm birth was defined as birth before 36 completed weeks of gesta-
tion (excluding the borderline 36th week), with delivery occurring with intact membranes or
following PPROM. Pregnancies with known risk factors for SPTB were excluded from the pri-
mary analyses.
Replication population: Danish sister pairs. This population set, recruited from Den-
mark, included 192 women from 95 families. This cohort consisted of 93 affected sister pairs
(both sisters have given birth preterm) and two sister triads with preterm deliveries. Preterm
delivery was set to occur before 37 completed weeks of gestation, and all women had experi-
enced at least one PTB. In the majority (83%) of the sister pairs, both sisters had experienced a
spontaneous PTB. All individuals were of the European ancestry.
Whole exome data generation
DNA samples of the 17 individuals from Discovery population were extracted from whole
blood and saliva samples using standard methods [45]. Although, using DNA from both blood
and saliva samples, there were no major difference in the overall sequencing metrics (align-
ment metrics or total number of variants) between the sample types. DNA samples were sub-
jected to exon specific next generation sequencing performed at the Center for Pediatric
Genomic Medicine, Children’s Mercy Hospital (CMH; Kansas City, MO). Exome samples
were prepared with the Illumina Nextera Rapid Capture Exome kit according to the manufac-
turer’s protocols as described previously [47]. Sequencing was performed on Illumina HiSeq
2500 instruments utilizing v4 chemistry with 2 x 125 nucleotide sequences. Sequence data
were generated with Illumina RTA 1.18.64.0 and bcl2fastq-1.8.4, and aligned against the refer-
ence human genome (GRCh37.p5) using bwa-mem [48], and variant calls were made using
the Genome Analysis Toolkit (GATK) [49] version 3.2–2 using previously described methods
[50]. Duplicate reads were identified and flagged with the Picard MarkDuplicates tool.
Realignment of reads around known indels was performed with the RealignerTargetCreator
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and IndelRealigner, and variants were called on individual samples using the HaplotypeCaller
modules of the GATK.
In addition, whole exome sequencing was performed on 192 affected individuals from 95
Danish families (Replication set). Exome capture of the samples were carried out with the BGI
Exon Kit following manufacturer’s protocols (BGI, Shenzhen, China). DNA libraries were gen-
erated using combinatorial Probe Anchor Ligation (cPAL) technology, and 35 base paired end
reads were generated from 500 bp genomic fragments. Whole exome sequencing was per-
formed using the Complete Genomics platform (BGI) and using the manufacturer’s pipeline.
Reads were aligned against the National Center for Biotechnology Information (NCBI) build
37 reference human genome.
Variant annotation, filtering and prioritizing
The variant call files (VCF), containing the variant call results, generated by CMH and BGI
were analyzed using Ingenuity Variant Analysis Software (Qiagen, Germany) and Golden
Helix VarSeq Software v.1.2.1 (Bozeman, MT) for both the Discovery and Replication popula-
tion sets. Variants were filtered based on variant quality control measurements, frequency and
predicted pathogenicity, as well as a dominant inheritance model.
In the Ingenuity Variant Analysis, low quality variants (read depth <15 and call quality
<20) were removed. Furthermore, we only included rare variants (i.e. MAF <1% in the 1000
Genomes Project, ExAC or in European American population in NHLBI ESP exomes) and
variants that would likely have functional effect (i.e. variants that are predicted by SIFT or
PolyPhen-2 as damaging or likely damaging, listed in Human Gene Mutation Database, or
associated with gain or loss of function of a gene).
In VarSeq, variants with read depth <15 and genotype quality score <20 were excluded.
Only rare variants in Europeans (MAF <1% or absent; 1kG Phase 3: Variant frequencies 5,
GHI Jan 2015) and missense or loss-of-function variants were included for analyses. Fur-
ther filtering was applied to the data obtained from VarSeq. Variant quality was enhanced
by applying range criteria (0.3–0.85) for alternative allele frequency (i.e. ratio of alternate
allele read depth / alternate allele read depth + reference allele read depth); variants outside
this range were excluded. Allele frequencies were searched from the Sequencing Initiative
Suomi (SISu) database (www.sisuproject.fi) for variants originating from the Finnish
mother data, and from the Exome Aggregation Consortium (ExAC) database (http://exac.
broadinstitute.org/) for Danish sister pair data. For these variants, a MAF cut-of value <1%
in Finnish general population (SISu) or European “non-Finnish” (ExAC) population was
used for Finnish or Danish mothers, respectively. The SISu database was used for Finnish
mothers to exclude rare variants that are enriched in Finnish general population compared
to the rest of the Europeans.
For the Discovery samples, we also used allele frequency calculations derived from Center
for Pediatric Genomic Medicine’s CMH Variant Warehouse database (http://warehouse.cmh.
edu) including ~3900 individuals previously sequenced at the center [50]. Pathogenicity was
categorized according to the American College of Medical Genetics [21] as 1; previously
reported to be disease-causing, 2; expected to be pathogenic (loss of initiation, premature stop
codon, disruption of stop codon, whole-gene deletion, frame shifting indel, and disruption of
splicing), and 3; unknown significance but potentially disease-causing (nonsynonymous sub-
stitution, in-frame indel, disruption of polypyrimidine tract, overlap with 5’ exonic, 5’ flank, or
3’ exonic splice contexts). Only variants that fit one of these criteria (1−3) were included for
analyses. Rare and novel variants with relatively high frequency in this internal control popula-
tion were also excluded as they were thought to be technical artifacts.
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Model of inheritance, gene and variant sharing filters
In Ingenuity Variant Analysis, a dominant inheritance model (including gain of function vari-
ants, and all heterozygous, compound heterozygous, haploinsufficient, hemizygous, and het-
ambiguous variants) was used to investigate predisposing variants that are inherited in the
families. When analyzing affected mothers as a group, rare variants in genes that were common
for a proportion of all cases were investigated. Whereas in family specific analyses, only vari-
ants that were shared by the affected individuals within each family were included.
Pathway analysis
Ingenuity Variant Analysis provides a list of most significant pathways calculated specifically
for each filtering output. P-values were calculated according to Fisher’s exact test assessing
overlap enrichment of dataset-variant genes relative to known phenotype-implicated genes.
Here, only pathways with p<0.01 were included for further analyses.
Investigation of rare variants in genome-wide association study data
To investigate rare variants in genes arising from the whole exome data in a larger population
setting including controls, we used available sources of preterm birth GWAS data. GWAS data
from a large cohort, identified among 23andMe’s research participants, included 43,568 moth-
ers of general European ancestry [14] and meta-analysis data including 4,632 mothers from
three independent Nordic (Finnish, Danish, and Norwegian) birth cohorts of European ances-
try [51]. In addition, a set of GWAS data from a total of 608 mothers passing quality control
measures was available. This set included mothers with spontaneous preterm deliveries and
mothers with term deliveries originating exclusively from northern Finland. Genotyping was
performed with Illumina Human CoreExome chip, followed by prephasing and imputation
procedures with ShapeIT2 [52] and IMPUTE2 [53]. Association analysis was performed using
SNPTEST v. 2.5.2 [54].
Resequencing the candidate variants
Since WES methodologies are associated with significant false positive rates, the presence of
interesting variant findings from WES analyses was confirmed using Sanger sequencing. Sam-
ples were sequenced using capillary electrophoresis with ABI3500xL Genetic Analyzer
(Applied Biosystems, CA) in Biocenter Oulu Sequencing Center, University of Oulu, Oulu,
Finland. Details of the PCR primers and reaction conditions are available upon request.
Assessing the functional impact of the rare HSPA1L variants using in silico
modeling
The possible functional effect of the rare HSPA1L variants (rs34620296 and rs150472288 from
Discovery analyses as well as rs482145 and rs139193421 from Replication analyses) were inves-
tigated using in silico prediction tools such as SIFT, PolyPhen-2, MutationTaster and Mutatio-
nAssessor. These pathogenicity predictions were annotated using Varseq, whereas CADD
scores to identify pathogenic and deleterious variants were obtained from Ingenuity. Variants
with CADD score >20 are amongst top 1% of deleterious variants in human genome [55].
RegulomeDB (http://www.regulomedb.org/) was used to investigate variant locations for e.g.
chromatin state activity. In addition, we used HaploReg v4.1 (http://archive.broadinstitute.
org/mammals/haploreg/haploreg.php) to assess whether variants are located within regions
that show evidence for promoter or enhancer activity (i.e. presence of histone modification
marks H3K4me1 and H3K27ac that are associated with enhancer regions, or H3K4me3 and
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H3K9ca that are associated with promoter regions), as well as for DNase I hypersensitivity in
human tissues and cell line samples.
We further investigated the potential effects that missense variation rs34620296
(Ala268Thr) could have on protein sequence or structure. We used NetPhos 3.1 [56] to investi-
gate possible changes in phosphorylation events in HSPA1L sequence. NetPhos 3.1 predicts
serine, threonine or tyrosine phosphorylation sites in amino acid sequences of eukaryotic pro-
teins. Evidence of being a phosphorylation site is given when the score is above the threshold
(0.5). To investigate the possible effects of missense variant in protein structure, the reference
protein structure and the modified protein structure, including the missense variant, were
compared. Original (UniProtKB: P34931) and modified (Ala268Thr) amino acid sequences
were submitted to SWISS-MODEL (https://swissmodel.expasy.org/) for protein modeling.
Resulting protein models were compared simultaneously using UCSF Chimera. Molecular
graphics and analyses were performed with the Chimera-1.11.2. package (https://www.cgl.
ucsf.edu/chimera/). Chimera was developed by the Resource for Biocomputing, Visualization,
and Informatics at the University of California, San Francisco (supported by NIGMS
P41-GM103311) [57].
In vitro functional analysis using human endometrial stromal fibroblasts
Construction of pcDNA 3.1(+) plasmid with HSPA1L inserts. pGEX-6P-1 vector
including HSPA1L WT or Ala268Thr inserts were generously provided by Dr. Michael Snyder
and Dr. Shinichi Takahashi from Stanford University. These vectors were generated as
described in their previous study [33]. To obtain a more suitable vector for human derived
cells, the HSPA1L inserts were cut from the pGEX-6P-1 vector using BamHI-HF (New
England Biolabs) and NotI (Invitrogen) restriction enzymes. The HSPA1L sequences were sub-
cloned into pcDNA3.1(+) vector (Invitrogen) by ligating into the BamHI/NotI sites using
Quick ligase (New England Biolabs). The recombinant plasmids (WT or Ala268Thr) were
sequenced to confirm the successful construction before continuing into further functional
studies.
Cell culture and transfection. Two primary human endometrial stromal fibroblast (ESF)
lines (HsESC_217S and HsESC_218S) were obtained from the Hugh Taylor/Clare Flannery
labs in the Department of Obstetrics, Gynecology, and Reproductive Sciences at Yale Univer-
sity. HsESC_217S and HsESC_218S were derived from two separate patients each undergoing
a polypectomy surgical procedure on days 3 and 9 of the menstrual cycle, respectively. ESFs
were cultured in DMEM (GIBCO), supplemented with 10% fetal bovine serum (FBS), 200mM
L-glutamine and 1% penicillin-streptomycin (GIBCO) in a humidified incubator at 37˚C with
5% CO2.
ESF cells were cultured in 6-well plates until confluent and transfected by Lipofectamine
3000 (Thermo Fisher Scientific) with 500ng WT HSPA1L-pcDNA3.1(+) or Ala268Thr
HSPA1L-pcDNA3.1(+) per well and maintained for 24h in OPTI-MEM reduced serum
medium (GIBCO). Cells transfected with empty pcDNA3.1(+) vector were used as control.
After 24h, the medium was replaced with fresh media (DMEM, 10% FBS, 200mM L-gluta-
mine, 1% penicillin) and cells were let to recover for 24h. To induce decidualization, cells were
treated with 0.5mM 8-Br-cAMP (Sigma) and 0.5mM of the progesterone analog, medroxy-
progesterone acetate (Sigma), for 72h in DMEM supplemented with 2% FBS, 1% penicillin
and sodium bicarbonate. Additionally, this media contained 100nM Dexamethasone (Sigma)
to mimic increased stress levels. After the 72h period, cells were harvested using Trypsin
(0.05% Trypsin, 0.5mM EDTA, PBS) for either protein or RNA extraction procedures. All
treatments were done as 3 replicates in three different passages (n = 9 each group).
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Western blotting. From the harvested cell pellet, protein was extracted using NE-PER
Nuclear and Cytoplasmic Extraction Kit (Thermo Fisher Scientific) according to the manufac-
turer’s instructions and stored at -80˚C until used. Protein content was assessed using Pierce
BSA Protein Assay (Thermo Fisher Scientific) according to the manufacturer’s instructions.
Denaturated protein samples (20 μg for cytoplasmic or 10 μg for nuclear proteins) were loaded
onto NuPAGE 4–12% Bis-Tris gels (Invitrogen) and separated by electrophoresis in 1x
NuPAGE MOPS SDS running buffer (Thermo Fisher Scientific). Protein bands were electro-
blotted onto a nitrocellulose membrane (GE Healthcare) using NUPAGE transfer buffer
(Thermo Fisher Scientific) and 20% methanol. After transferring the bands, membranes were
blocked in 5% nonfat dry milk in Tris buffered saline (TBS; Fisher Scientific) containing 0.1%
Tween 20 (Sigma) for 1h in RT. Membranes were incubated overnight in +4˚C with primary
monoclonal rabbit antibodies against HSPA1L (dilution 1:1000; GTX111045; GeneTex), GR
(dilution 1:1000; #3660S; Cell Signaling Technologies) or, as control, β-actin (dilution 1:
20,000; A5060; Sigma) in 5% nonfat dry milk TBS-0.1%Tween. In the following day, mem-
branes were washed with TBS-0.1%Tween and incubated with horseradish peroxidase conju-
gated goat anti-rabbit IgG secondary antibody (dilution 1: 10,000; sc-2004; Santa Cruz
Biotechnology) for one hour in RT. Membranes were washed with TBS-0.1%Tween, and for
luminol based band detection, treated with Super Signal West Pico or Dura Luminol (Thermo
Fisher Scientific). Protein band intensities of HSPA1L and GR were quantified relative to cor-
responding β-actin band (i.e. protein of interest: β-actin ratio) using Image J. The data was
tested for normality, and one-way ANOVA in GraphPad Prism v.7.04 (GraphPad Software,
Inc.) was used to compare the protein levels. Statistical significance was defined as a p<0.05.
RNA extraction, cDNA synthesis and real-time quantitative PCR. Total RNA was
extracted using the RNeasy Mini Kit (Qiagen). cDNA synthesis from total RNA was performed
using Quantitect Reverse Transcription Kit (Qiagen) according to manufacturer’s instructions.
Expression levels of mRNA were determined by real-time quantitative PCR (qPCR) on Step
One Plus real-time PCR system (Applied Biosystems). Amplification reactions were performed
as duplicate in 20μl final volume containing 25ng cDNA, WNT4 and GAPDH TaqMan gene
expression assays (Hs01573505_m1 and Hs02758991_g1, respectively, Thermo Fisher Scien-
tific), and 2x TaqMan Gene Expression Master Mix (Thermo Fisher Scientific). GAPDH was
used as a housekeeping gene. Relative quantification of WNT4 was performed using the ΔΔCt
method. One-tailed Student’s t test was used to compare gene expression levels.
Supporting information
S1 Fig. Pedigrees of the seven northern Finnish multiplex families with recurrent sponta-
neous preterm births. Circles represent females and squares males; symbols with a line inter-
secting indicate that individual is deceased. Diamonds denote an unspecified number of
infants born at term, i.e. gestational age (GA)37 weeks. Letters above symbols indicate indi-
viduals for whom WES data was gathered and an asterisk next to the letter denotes the individ-
ual as a recurrent mother. Letters inside brackets indicate grandmothers with term, twin or
non-spontaneous deliveries, and were not included in the primary analyses. Pedigrees were
created using Progeny Pedigree tool (https://pedigree.progenygenetics.com/).
(PDF)
S2 Fig. Comparison of Finnish (Discovery) and Danish (Replication) family analyses. For
both the Discovery (total of 5 families) and Replication (total of 93 families) populations, these
analyses only included rare variants that passed the filters of multiple annotating software
tools and were shared by affected family members. The total number of genes (A) and variants
(B) that were common between the two populations are presented in the middle of the Venn
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diagram.
(TIF)
S3 Fig. Phosphorylation site prediction results. The potential effect of Ala268Thr on
HSPA1L protein sequence was predicted using NetPhos 3.1. This missense variant generates
an additional phosphorylation site on the HSPA1L sequence with high confidence (0.855;
above the threshold of 0.5). The T268-p phosphorylation site is marked with an asterisk.
(TIF)
S4 Fig. Tissue expression of HSPA1L, AR, NCOA3 and NCOR2 in pregnancy related tissues.
(A) HSPA1L is expressed with reasonable confidence in placental tissue (0.65), ovarian (0.57)
and fetal tissues (0.48) as well as in uterus (0.29). (B) For HSPA1L, AR, NCOA3 and NCOR2
together, the average expression confidence is high in placenta (0.74), ovary (0.70), fetus
(0.65), and moderate in uterus (0.29), indicating high confidence for expression in female
reproductive system overall. Tissue expression was established using HumanBase (http://hb.
flatironinstitute.org).
(TIF)
S1 Table. Pathway results for Finnish mothers with recurrent preterm births (n = 10).
(DOCX)
S2 Table. Pathway results for Finnish families (n = 5) with multiple affected individuals:
Only pathways seen in at least two different families are listed.
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S3 Table. Pathway results for Danish sister pairs (n = 93): only pathways common for20
families are listed.
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S4 Table. Comparison of variant filtering results from different analysis software used for
Finnish families with multiple affected individuals (n = 5).
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Sonja Eeli, Miia Lehto and Riitta Vikeväinen from Oulu University Hospital are acknowledged
for sample and data collection. Heather Brockway is acknowledged for her expertise and guid-
ance on the in silico protein modeling work. Our sincere thanks to Dr. Michael Snyder and Dr.
Shinichi Takahashi from Stanford University School of Medicine for providing the WT and
Ala268Thr HSPA1L-pGEX-6P-1 plasmid constructs. We also thank the participants in the
Whole exome sequencing in spontaneous preterm birth
PLOS Genetics | https://doi.org/10.1371/journal.pgen.1007394 July 12, 2018 18 / 22
Finnish birth cohort (FIN), Mother Child Cohort of Norway (MoBa), and Danish National
Birth Cohort (DNBC). GWAS data for the preterm birth project within the Norwegian Mother
and Child Cohort Study are supported by the Norwegian Ministry of Health and Care Services
and the Ministry of Education and Research, NIH/NIEHS (contract no. N01-ES-75558), NIH/
NINDS (grant no.1 UO1 NS 047537–01 and grant no.2 UO1 NS 047537-06A1). GWAS data
for the preterm birth project DNBC samples were generated within the GENEVA consortium
with funding provided through the NIH Genes, Environment, and Health Initiative (GEI, pre-
term birth: U01HG004423, dbGaP accession number phs000103.v1.p1). The GENEVA Coor-
dinating Center (U01HG004446) provided assistance with genotype cleaning and general
study coordination.
We thank the research participants and employees of 23andMe for making this work possi-
ble, including the following members of the 23andMe Research Team: Michelle Agee, Babak
Alipanahi, Adam Auton, Robert K. Bell, Katarzyna Bryc, Sarah L. Elson, Pierre Fontanillas,
Nicholas A. Furlotte, Bethann S. Hromatka, Karen E. Huber, Aaron Kleinman, Matthew H.
McIntyre, Joanna L. Mountain, Carrie A.M. Northover, Steven J. Pitts, J. Fah Sathirapongsa-
suti, Olga V. Sazonova, Janie F. Shelton, Suyash Shringarpure, Chao Tian, Joyce Y. Tung, Vla-
dimir Vacic, Catherine H. Wilson.
Author Contributions
Conceptualization: Johanna M. Huusko, Jeffrey C. Murray, Mika Rämet, Stephen F. King-
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